EUVIMEDOpdag EUVIMED
Open access

An Antibiotic‐Free Cryptic Plasmid Platform for Modular Pathway Coupling in Probiotic Escherichia Coli Nissle 1917

Xue Cai, Jie Cui, Lu Xiong, Jing-Hui Cao, Xin-Yan Lu, Jingjing Shi, Bo Zhang, Zhi-Qiang Liu iD, Yu-Guo Zheng

Biotechnology and Bioengineering · 2026-09 · 123 (9) · 2260-2274

DOI: 10.1002/bit.70254 ↗

At a glance

Journal article in Biotechnology and Bioengineering, published online on 2026-06-07. Written by Xue Cai and 8 co-authors. Institution: Huadong Industry Technology Institute of Synthetic Biology, Zhejiang University of Technology, Hangzhou, Zhejiang, China. Major MEDLINE topics: Escherichia coli, Plasmids, Metabolic Engineering, Probiotics. Cited 1 times so far (Crossref); 37 references. The full text is freely available in PubMed Central. Funded by: Huadong Medicine Joint Fund of the Zhejiang Provincial Natural Science Foundation of China, Central Guidance on Local Science and Technology Development Fund of Zhejiang Province.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Escherichia coli Nissle 1917 (EcN) is a well‐established probiotic chassis with an excellent safety profile; however, its application as an industrial microbial cell factory remains limited, largely due to genetic instability and antibiotic‐dependent expression systems. In this study, we developed an antibiotic‐free and genetically stable metabolic engineering strategy for vitamin B 5 (VB 5 ) biosynthesis in EcN by integrating global regulatory rewiring with a cryptic plasmid–based pathway coupling platform. To enhance precursor supply, the VB 5 biosynthetic pathway was reinforced by coordinated expression of AlsS, PanB, and PanC, leading to improved ketopantoate accumulation. Deletion of the global transcriptional regulators CRP and CRA significantly reshaped carbon metabolism, as revealed by transcriptomic analysis, resulting in enhanced transcription of key pathway genes and increased specific VB 5 productivity despite reduced cellular growth. To overcome plasmid instability and metabolic burden associated with conventional expression systems, native cryptic plasmids (pMUT1 and pMUT2) were engineered as modular expression platforms. Positional integration of pathway genes into cryptic plasmids enabled tunable gene expression and ensured long‐term genetic stability without antibiotic selection. The optimized strain harboring the complete VB 5 pathway on engineered cryptic plasmids produced 98 mg/L VB 5 in shake‐flask cultures with stable productivity over multiple passages. In a 5‐L fed‐batch bioreactor, VB 5 titer reached 1.15 g/L, representing an 11.8‐fold improvement compared with flask cultivation. This work establishes a robust cryptic plasmid–based pathway engineering framework for probiotic E. coli , highlighting its potential as a safe, stable, and scalable chassis for antibiotic‐free production of value‐added metabolites.

Subjects

MeSH terms (MEDLINE)

Escherichia coliPlasmidsMetabolic EngineeringProbioticsMetabolic Networks and PathwaysAnti-Bacterial Agents

Author keywords

Escherichia coli Nissle 1917antibiotic‐freecarbon redistributioncryptic plasmidgenetic stability

Substances

Anti-Bacterial Agents

Authors and institutions

  • Huadong Industry Technology Institute of Synthetic Biology, Zhejiang University of Technology, Hangzhou, Zhejiang, China.
  • State Key Laboratory of Green Chemical Synthesis and Conversion, Zhejiang University of Technology, Hangzhou, Zhejiang, China.
  • Zhejiang Key Laboratory of Bioorganic Synthesis, Zhejiang University of Technology, Hangzhou, Zhejiang, China.
  • The National and Local Joint Engineering Research Center for Biomanufacturing of Chiral Chemicals, Zhejiang University of Technology, Hangzhou, Zhejiang, China.

ORCID profiles: Zhi-Qiang Liu

Funding

  • Huadong Medicine Joint Fund of the Zhejiang Provincial Natural Science Foundation of China
  • Central Guidance on Local Science and Technology Development Fund of Zhejiang Province

Cite

APA

Cai, X., Cui, J., Xiong, L., Cao, J. H., Lu, X. Y., Shi, J., Zhang, B., Liu, Z. Q., & Zheng, Y. G. (2026). An Antibiotic‐Free Cryptic Plasmid Platform for Modular Pathway Coupling in Probiotic Escherichia Coli Nissle 1917. Biotechnology and Bioengineering, 123(9), 2260-2274. https://doi.org/10.1002/bit.70254

Vancouver

Cai X, Cui J, Xiong L, Cao JH, Lu XY, Shi J, et al. An Antibiotic‐Free Cryptic Plasmid Platform for Modular Pathway Coupling in Probiotic Escherichia Coli Nissle 1917. Biotechnology and Bioengineering. 2026;123(9):2260-2274. doi:10.1002/bit.70254

BibTeX
@article{Cai2026,
  author = {Cai, Xue and Cui, Jie and Xiong, Lu and Cao, Jing-Hui and Lu, Xin-Yan and Shi, Jingjing and Zhang, Bo and Liu, Zhi-Qiang and Zheng, Yu-Guo},
  title = {An Antibiotic‐Free Cryptic Plasmid Platform for Modular Pathway Coupling in Probiotic Escherichia Coli Nissle 1917},
  journal = {Biotechnology and Bioengineering},
  year = {2026},
  volume = {123},
  number = {9},
  pages = {2260--2274},
  doi = {10.1002/bit.70254}
}
Start for free →